Pharmaceutical - Financial, Takeda Pharmaceuticals


Popular Filters

Takeda Pharma six-month profits down, despite sales growth

Takeda Pharma six-month profits down, despite sales growth


Takeda Pharmaceuticals, Japan’s largest drugmaker, this morning posted financial results for the six…

FinancialPharmaceuticalTakeda Pharmaceuticals

Takeda partners with newly-formed Tri-1 TDI

Takeda partners with newly-formed Tri-1 TDI


The USA’s Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical…

Asia-PacificFinancialNorth AmericaPharmaceuticalResearchTakeda Pharmaceuticals

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production


The Russian Yaroslavl region is expected to become one of the major centers of the country’s pharmaceutical…

AbbVieCadila PharmaceuticalsEuropeFinancialPharmaceuticalProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

Top-line financials for Japanese drug majors


Among a flurry of first-quarter fiscal 2013/14 financial results released by Japanese drug majors, the…

Dainippon Sumitomo PharmaEisaiFinancialMitsubishi TanabePharmaceuticalTakeda Pharmaceuticals

Evolution of Japan's pharma wholesalers - by P Reed Maurer


Half of the definition for evolution (noun; a gradual process in which something changes especially into…

Asia-PacificFinancialMitsubishi TanabePharmaceuticalProductionSankyoShionogiTakeda Pharmaceuticals

$10 million milestone for Sucampo, as Takeda starts US selling of Amitiza for OIC


USA-based Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a $10 million milestone payment…

AmitizaFinancialGastro-intestinalsMarkets & MarketingNorth AmericaPharmaceuticalSucampoTakeda Pharmaceuticals

Top-line financial results from Japanese drug majors


Among a batch of Japanese drug majors presenting fiscal year 2013 (ended April 2013) financial results,…

Dainippon Sumitomo PharmaFinancialMitsubishi TanabePharmaceuticalShionogiTakeda Pharmaceuticals

MHLW joins Japan's first P-PP to facilitate R&D of new health technologies for the developing world


The Japanese Ministry of Health, Labor and Welfare (MHLW) has said it supports the research and development…

Asia-PacificAstellas PharmaDaiichi SankyoEisaiFinancialHealthcarePharmaceuticalResearchShionogiTakeda PharmaceuticalsTropical diseases

Takeda, Shionogi, Ono Pharma and Mitsubishi Tanabe post nine-month results


Takeda Pharmaceuticals (TYO: 4502), Japan's largest drugmaker, has reported nine-month 2013 results with…

FinancialMitsubishi TanabeOno PharmaceuticalPharmaceuticalShionogiTakeda Pharmaceuticals

Infinity amends PI3K-delta, gamma accord with Millennium


US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) says it has amended its development and…

BiotechnologyFinancialInfinity PharmaceuticalsIPI-145LicensingMillennium PharmaceuticalsPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

Takeda's leadership as Japan's largest drugmaker set to decline, says DR


Based on full-year 2011 sales, Japan's Takeda Pharmaceutical (TYO: 4502) maintained its position as the…

Asia-PacificAstellas PharmaFinancialPharmaceuticalResearchTakeda Pharmaceuticals

Japan's drug majors post mixed financial results


Japan's leading drugmakers rolled out financial results for the first fiscal quarter of 2013, ended June…

Daiichi SankyoDainippon Sumitomo PharmaFinancialKyowa Hakko KirinPharmaceuticalTakeda Pharmaceuticals

Takeda completes URL acquisition which will immediately boost revenues


Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) said yesterday that it has now completed…

ColcrysFinancialMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsURL Pharma

Takeda posts downturn in sales for FY 2012; forecasts operating profit slump


Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) posted disappointing results for its fiscal…

FinancialPharmaceuticalTakeda Pharmaceuticals

Back to top